Jul. 8 at 2:34 AM
$CANF Can-Fite has Great Products with Great Potentials in Advance Clinical Trials which concievably could become Massive Winners some day... but that day is far, far away given how awful the stock performs... they lack the insight of obtaining Institutional Backing and Management Takes Out way too much for themselves. They're always raising small amounts, althought still in the Million$, using Shareholder as their ATM, Shorts beat it down, Pump & Dump.... Reverse Split, Short, Dilute... Rinse & Repeat. It's a No-Win for Shareholders only endless Losses...-99.99% Losses for those holding long term Shares without Support It'll Always Go Down, unless they get a viable Institutional backer, or a buyout. It's a shame not to do it the right way... Market Cap should be in the Billion$ and Shares Should be reflective of a winner, say at least
$40. +
